Marathon CIO Robert Mullin reveals why gold stocks are still undervalued

The son of a stockbroker, Mr Mullin has more than 30 years' investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.
Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.

Joseph Carbone

Marathon CIO Robert Mullin reveals why gold stocks are still undervalued

October 5, 2025
The son of a stockbroker, Mr Mullin has more than 30 years' investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.
Read Transcript

A self-proclaimed “code-breaker”, Robert Mullin has made a career charting the different storylines in the “soap opera” of markets. He says he knows when the dramatic crescendos are coming and which storylines are just beginning.


But, like with the soaps, the most entertaining and outlandish times in markets can seem too-far fetched to dive in fully.


The son of a stockbroker, Mr Mullin has more than 30 years’ investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.


Mr Mullin operates Marathon’s sole fund, which focuses on investment in resources and natural resources equities, with the fund generating more than 30 per cent annual returns since 2020, compared to the 8 per cent generated by the S&P Global Natural Resources Index.


Mr Mullin says his “classic value investor” approach is “anachronistic” in an age when popular themes and stocks get support based on popular trends, the news of the day and “bigness”.


“To me, it’s a very logical thing about looking at companies and cash flows and their ability to generate cash flow over time,” he tells The Australian. “And then building a structure on that to figure out how much I want to pay for it.”


His propensity for sequencing and maths has helped him carve out his niche, focusing on the resources sector, he says.


“My ability to look and understand evolution and flows in numbers over time is pretty good. And that lends itself to raw materials investing, because you’re talking about the tangible ability of these companies to generate cash flows over time.


“As opposed to, you know, I’m not going to be able to tell you who the next, great AI winner is.


“I’m a classic value investor, and that’s something that requires math. And a lot of things I look at in the world of investing today, (it) seems like the math requirement has been lifted.”


Mr Mullin will be speaking as a featured stock picker at the Sohn Hearts & Minds conference at the Sydney Opera House in November, the 10th anniversary of the event. Sohn has so far raised $84m for medical research.


The event comes as markets continue to perform despite heightened geopolitical volatility and social anxiety. The continued, record-breaking support markets have found (the three major Wall St indices are up from between around 9 and 17 per cent since the start of the calendar year) has a suspicious Mr Mullin playing a lot of defence.


“We’re in a period of time of economic volatility, geopolitical turmoil, socio-economic turmoil. And that doesn’t seem to me totally consistent with US markets, the most richly valued markets in the history of markets.


“This is a period of time where you want to have elements … that are defensive, that are grounded, that are based in something where you don’t have to make sure that your company hits the next long ball and is the winner in AI.


“The AI theme is one that is so big and so difficult to really understand and grasp, that those associated with it are simply getting the benefit of the doubt that they’ll be able to turn those into economic businesses.


“I still think there’s an opportunity to be a great value guy, and we’ve done very well for our investors, having a very disciplined approach buying companies the old-fashioned way.”


The stunning and continued rise of gold is one of those storylines Mr Mullin believes is still “in its middle innings”.


The price of gold has surged almost 50 per cent so far this calendar year to around $US3878.90 per ounce. In Australia, stocks in gold miners have followed suit, with Northern Star (58 per cent higher), Newmont (116.1 per cent) and Evolution (128.9 per cent) outperforming their resource sector peers so far in calendar 2025.


“People make the gold market too complicated,” Mr Mullin says. “They say it’s an inflation play or a deflation play, or it’s a play on negative real interest rates (or) a depreciation of the dollar. Too complicated.


“What gold has shown us over the past decade is it’s just a really good, diversifying, anti-correlated asset in a period of time where people hold a lot of US dollar, and dollar denominated assets, worldwide.”


And Mr Mullin believes gold still has a lot of value for investors.


“The remarkable thing is … in the third quarter of 2024, gold was 2400, 2500 bucks, and these (gold) stocks were trading at two or three times cash flow. Now the stocks are all up 100 per cent, but gold is at 3700 bucks, and they’re all still trading at two times cash flow.


“So the world is slowly coming around … but they’re not expensive by any stretch of the imagination.


“Gold stocks are (now) actually cheaper than they were last year.”


And while he can’t disclose which stock he will be picking at Sohn, Mr Mullin says his presentation will focus on the “old economy/new economy dance” in the resources sector.


“What I think most people don’t understand is that (resources stocks) are mostly old economy businesses, but there are some very ‘new economy’ applications of current tech that I think are very fascinating.”


The Sohn Hearts & Minds conference will be held at the Sydney Opera House on Friday, November 14, 2025. Tickets can be purchased at sohnheartsandminds.com.au.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

A self-proclaimed “code-breaker”, Robert Mullin has made a career charting the different storylines in the “soap opera” of markets. He says he knows when the dramatic crescendos are coming and which storylines are just beginning.


But, like with the soaps, the most entertaining and outlandish times in markets can seem too-far fetched to dive in fully.


The son of a stockbroker, Mr Mullin has more than 30 years’ investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.


Mr Mullin operates Marathon’s sole fund, which focuses on investment in resources and natural resources equities, with the fund generating more than 30 per cent annual returns since 2020, compared to the 8 per cent generated by the S&P Global Natural Resources Index.


Mr Mullin says his “classic value investor” approach is “anachronistic” in an age when popular themes and stocks get support based on popular trends, the news of the day and “bigness”.


“To me, it’s a very logical thing about looking at companies and cash flows and their ability to generate cash flow over time,” he tells The Australian. “And then building a structure on that to figure out how much I want to pay for it.”


His propensity for sequencing and maths has helped him carve out his niche, focusing on the resources sector, he says.


“My ability to look and understand evolution and flows in numbers over time is pretty good. And that lends itself to raw materials investing, because you’re talking about the tangible ability of these companies to generate cash flows over time.


“As opposed to, you know, I’m not going to be able to tell you who the next, great AI winner is.


“I’m a classic value investor, and that’s something that requires math. And a lot of things I look at in the world of investing today, (it) seems like the math requirement has been lifted.”


Mr Mullin will be speaking as a featured stock picker at the Sohn Hearts & Minds conference at the Sydney Opera House in November, the 10th anniversary of the event. Sohn has so far raised $84m for medical research.


The event comes as markets continue to perform despite heightened geopolitical volatility and social anxiety. The continued, record-breaking support markets have found (the three major Wall St indices are up from between around 9 and 17 per cent since the start of the calendar year) has a suspicious Mr Mullin playing a lot of defence.


“We’re in a period of time of economic volatility, geopolitical turmoil, socio-economic turmoil. And that doesn’t seem to me totally consistent with US markets, the most richly valued markets in the history of markets.


“This is a period of time where you want to have elements … that are defensive, that are grounded, that are based in something where you don’t have to make sure that your company hits the next long ball and is the winner in AI.


“The AI theme is one that is so big and so difficult to really understand and grasp, that those associated with it are simply getting the benefit of the doubt that they’ll be able to turn those into economic businesses.


“I still think there’s an opportunity to be a great value guy, and we’ve done very well for our investors, having a very disciplined approach buying companies the old-fashioned way.”


The stunning and continued rise of gold is one of those storylines Mr Mullin believes is still “in its middle innings”.


The price of gold has surged almost 50 per cent so far this calendar year to around $US3878.90 per ounce. In Australia, stocks in gold miners have followed suit, with Northern Star (58 per cent higher), Newmont (116.1 per cent) and Evolution (128.9 per cent) outperforming their resource sector peers so far in calendar 2025.


“People make the gold market too complicated,” Mr Mullin says. “They say it’s an inflation play or a deflation play, or it’s a play on negative real interest rates (or) a depreciation of the dollar. Too complicated.


“What gold has shown us over the past decade is it’s just a really good, diversifying, anti-correlated asset in a period of time where people hold a lot of US dollar, and dollar denominated assets, worldwide.”


And Mr Mullin believes gold still has a lot of value for investors.


“The remarkable thing is … in the third quarter of 2024, gold was 2400, 2500 bucks, and these (gold) stocks were trading at two or three times cash flow. Now the stocks are all up 100 per cent, but gold is at 3700 bucks, and they’re all still trading at two times cash flow.


“So the world is slowly coming around … but they’re not expensive by any stretch of the imagination.


“Gold stocks are (now) actually cheaper than they were last year.”


And while he can’t disclose which stock he will be picking at Sohn, Mr Mullin says his presentation will focus on the “old economy/new economy dance” in the resources sector.


“What I think most people don’t understand is that (resources stocks) are mostly old economy businesses, but there are some very ‘new economy’ applications of current tech that I think are very fascinating.”


The Sohn Hearts & Minds conference will be held at the Sydney Opera House on Friday, November 14, 2025. Tickets can be purchased at sohnheartsandminds.com.au.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Oct 05, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Azora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee Nowytarger
November 17, 2023

Webster Financial ‘Avoided The Mistakes Of US Bank Failures’

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
November 17, 2023

Why Stock Picker Cathie Wood Of ARK Can’t Stand Google

The world’s highest-profile tech investor, Cathie Wood, might be bruised but she is certainly bullish. Nor is she holding back.

Read More
Munro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee Nowytarger
November 17, 2023

Wise Share Price Could Rise 50pc By 2025, Says Munro Partners

Global growth fund manager Munro has about $4.3bn in funds under management across four global funds, and usually invests in companies that are poised to win from massive structural change.

Read More
November 16, 2023

Hedge Fund Veteran Talks Lowest Moment In Toscafund’s 23-Year Run

Most hedge fund managers brag about their wins and shy away from their losses – Martin Hughes is not most hedge fund managers.

Read More
November 16, 2023

The ‘Armageddon Scenario’ Worrying The Future Fund CIO

Mr Samild shared his thoughts on the bond market – which underpins the returns of other assets – ahead of his appearance at Friday’s Sohn Hearts & Minds charity conference at the Sydney Opera House.

Read More
Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 15, 2023

Ashish Swarup - Invest In Snacks, Let's Get That Bread | Aikya Investment Management

Ashish Swarup, Portfolio Manager and Investment Analyst of Aikya Investment Management joins Bryce and Ren to discuss emerging markets, and two stock deep dives.

Read More
November 15, 2023

Daniel Loeb’s Wall St Hedge Fund Third Point Raises Bets On Corporate Credit Crunch

An “obsession” around balance sheet strength and debt is creating a new wave of investment bets for the influential Wall Street hedge fund run by Daniel Loeb.

Read More
November 13, 2023

Bond Bullish On Commodity Stocks, Uranium

Mining stocks are poised to rise amid tight supply for key commodities such as copper, nickel and uranium, says Terra Capital founder Jeremy Bond.

Read More
November 13, 2023

This Hedge Fund Manager Is Making A 100-Year Bet On Luxury

European leisure and luxury – a designer handbag, a last-minute flight to Monte Carlo, a stay in a five-star hotel – is where many choose to spend their hard-earned cash. For Sharif el Khazen, it’s where he makes it.

Read More
November 12, 2023

How Munro Will Pick Its Next Stock Winner

Munro partner and portfolio manager Kieran Moore must select a single company to pitch to an audience of industry heavyweights at the prestigious Sohn Hearts & Minds conference in Sydney.

Read More
November 12, 2023

The Australian At The Centre Of Dalio’s Bridgewater – Who Loves It

The culture at Ray Dalio’s massive hedge fund has been a source of intrigue, and with a new book, controversy. Atul Lele says it’s made him a better investor.

Read More
November 10, 2023

Meet The Goldman Sachs Legend Shaking Up Venture Capital

Sheila Patel says it was time for the venture capital sector to “grow up” and higher rates will help do that job. VC firms need to think differently about how they invest.

Read More
November 8, 2023

Tom Naughton - There's Money In Mi Goreng | Prusik Investment

Tom Naughton is Managing Partner and CIO at Prusik Investment. In this episode, he chats to Equity Mates ahead of his appearance at the 2023 Sohn Hearts and Minds Conference.

Read More
November 6, 2023

Why Chris Kourtis just bought CSL and ResMed

A true contrarian investor, Chris Kourtis can find himself sounding a lot like a bull when in the company of bears, and there’s a lot to be bearish about at the moment.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.